These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2979730)
1. Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+. Wu E; Shinka T; Caldera-Munoz P; Yoshizumi H; Trevor A; Castagnoli N Chem Res Toxicol; 1988; 1(3):186-94. PubMed ID: 2979730 [TBL] [Abstract][Full Text] [Related]
2. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone. Yoshihara S; Ohta S Arch Biochem Biophys; 1998 Dec; 360(1):93-8. PubMed ID: 9826433 [TBL] [Abstract][Full Text] [Related]
3. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442 [TBL] [Abstract][Full Text] [Related]
4. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae. Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651 [TBL] [Abstract][Full Text] [Related]
5. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Castagnoli N; Chiba K; Trevor AJ Life Sci; 1985 Jan; 36(3):225-30. PubMed ID: 3871243 [TBL] [Abstract][Full Text] [Related]
6. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium. Shi H; Noguchi N; Xu Y; Niki E FEBS Lett; 1999 Nov; 461(3):196-200. PubMed ID: 10567696 [TBL] [Abstract][Full Text] [Related]
7. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases. Singer TP; Salach JI; Castagnoli N; Trevor A Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461 [TBL] [Abstract][Full Text] [Related]
8. Comparative toxicity and antioxidant activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B-generated metabolites in isolated hepatocytes and liver microsomes. Ekström G; Di Monte D; Sandy MS; Smith MT Arch Biochem Biophys; 1987 May; 255(1):14-8. PubMed ID: 3496045 [TBL] [Abstract][Full Text] [Related]
9. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO). Herraiz T; Arán VJ; Guillén H Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B. Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094 [TBL] [Abstract][Full Text] [Related]
11. Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW J Pharmacol Exp Ther; 1991 Aug; 258(2):594-600. PubMed ID: 1907660 [TBL] [Abstract][Full Text] [Related]
12. Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+. Schildknecht S; Pape R; Meiser J; Karreman C; Strittmatter T; Odermatt M; Cirri E; Friemel A; Ringwald M; Pasquarelli N; Ferger B; Brunner T; Marx A; Möller HM; Hiller K; Leist M Antioxid Redox Signal; 2015 Nov; 23(13):1001-16. PubMed ID: 26413876 [TBL] [Abstract][Full Text] [Related]
13. Mutagenicity of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its metabolites. Cashman JR Toxicology; 1987 Feb; 43(2):173-82. PubMed ID: 2949395 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of monoamine oxidase by 3,3-dimethyl analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl-2,3-dihydropyridinium ion. Dramatic effect of beta-mercaptoethanol on substrate turnover and enzyme inactivation. Hiebert CK; Sayre LM; Silverman RB J Biol Chem; 1989 Dec; 264(36):21516-21. PubMed ID: 2600079 [TBL] [Abstract][Full Text] [Related]
15. Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes. Di Monte D; Ekström G; Shinka T; Smith MT; Trevor AJ; Castagnoli N Chem Biol Interact; 1987; 62(2):105-16. PubMed ID: 3496169 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions. Weissman J; Trevor A; Chiba K; Peterson LA; Caldera P; Castagnoli N; Baillie T J Med Chem; 1985 Aug; 28(8):997-1001. PubMed ID: 3874963 [TBL] [Abstract][Full Text] [Related]
17. Processing of MPTP by monoamine oxidases: implications for molecular toxicology. Trevor AJ; Singer TP; Ramsay RR; Castagnoli N J Neural Transm Suppl; 1987; 23():73-89. PubMed ID: 3295117 [TBL] [Abstract][Full Text] [Related]
18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A. Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758 [TBL] [Abstract][Full Text] [Related]
19. Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Ottoboni S; Carlson TJ; Trager WF; Castagnoli K; Castagnoli N Chem Res Toxicol; 1990; 3(5):423-7. PubMed ID: 2133093 [TBL] [Abstract][Full Text] [Related]
20. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chiba K; Peterson LA; Castagnoli KP; Trevor AJ; Castagnoli N Drug Metab Dispos; 1985; 13(3):342-7. PubMed ID: 2861994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]